Labor Market Pulse · Life Sciences · October 2026
Life Sciences Labor Market Report: OR NONMETROPOLITAN AREA — October 2026
Oregon's rural life sci talent pool is tighter than the jobless rate suggests.
Oregon's nonmetro unemployment sits near 5.0%, yet Regulatory Affairs pay locally climbed to $114,400 even as the national figure fell, exposing a credentialed-talent shortage general labor data conceals.
Free archive edition. Published by WageScape as sent to subscribers; data as of October 2026.
Key indicators
- Oregon unemployment rate: 5.0% — vs 4.1% U.S. rate, Sept 2026
- Regulatory Affairs pay, metro: $114,400 median — Up significantly vs national decline to $103,780
- National quit rate: 1.9% — Signals low voluntary turnover among specialists
- Oregon biotech talent concentration: 2.5x national average — Enables semiconductor-to-biotech hiring crossover
Key takeaways
General unemployment masks a credentialed-talent shortage.
Statewide joblessness near 5.0% suggests labor availability, but regulatory affairs, quality, and CRA roles remain candidate-driven with national lab/R&D vacancy at 23.2% in top markets. Headcount plans for nonmetro facilities should treat specialist roles as a separate, tighter labor pool from the headline rate.
Semiconductor-to-biotech talent flow is a nonmetro advantage.
Oregon's biotechnology concentration runs roughly 2.5 times the national average, with workers moving fluidly between semiconductor and life sciences employers. Leaders in Bend and similar hubs may find faster technical hiring by recruiting directly from adjacent chip manufacturers, expanding beyond competition confined to life sciences talent pools.
Regulatory Affairs pay is climbing against a falling national trend.
Metro advertised pay for Regulatory Affairs Specialist rose to a median of $114,400 even as the national median declined, consistent with acute local demand tied to quality and pharmacovigilance gaps flagged statewide. Compensation benchmarking for this role should weight local trajectory over national averages through year-end.
Quit rates near 1.9% raise the cost of losing key scientists.
National quit rates near historic lows mean experienced regulatory, clinical, and biostatistics staff are largely staying put, so departures from nonmetro teams likely reflect targeted competitive offers against a backdrop of general churn. Retention reviews focused on counteroffer exposure in Biostatistician and Clinical Data Manager roles, both showing significant local pay increases, may be more productive than broad-based raises.
Median advertised pay by role — OR NONMETROPOLITAN AREA
| Role | 25th percentile | Median advertised pay | 75th percentile | Metro trend | National median |
|---|---|---|---|---|---|
| Research Scientist * | $130,670 | $147,973 | $148,237 | Stable | $130,339 |
| Clinical Research Associate | $100,225 | $129,331 | $136,976 | Stable | $90,065 |
| Lab Technician | $69,846 | $76,960 | $78,224 | Moderate increase | $47,840 |
| Regulatory Affairs Specialist * | $89,038 | $114,400 | $118,621 | Significant increase | $103,780 |
| Clinical Data Manager * | $112,499 | $150,104 | $220,000 | Significant increase | $123,653 |
| Biostatistician * | $116,478 | $170,439 | $170,747 | Significant increase | $131,958 |
| Validation Engineer * | $93,496 | $110,207 | $115,014 | Stable | $106,478 |
* State-level figure shown where metro postings were too few.
WageScape's median is calibrated to correct for spurious low-value postings (reported as the 60th percentile of raw advertised pay). Download: CSV · JSON
Local market conditions
Oregon's nonmetropolitan labor market remains structurally tight, with statewide unemployment holding near 5.0% for 19 consecutive months against a national rate of 4.1%, signaling persistent slack in rural labor pools even as specialized sectors tighten. Life sciences employers in these outlying areas draw on a biotechnology talent concentration nearly 2.5 times the national average, but compete directly with Bend-area semiconductor employers and the Thermo Fisher Bend site for the same technical and manufacturing workforce.
What it means
Rural Oregon's elevated general unemployment coexists with acute scarcity in regulatory affairs, quality, and biomanufacturing roles, meaning headcount plans built on broad labor slack will misread the actual difficulty of filling credentialed positions. Cross-industry mobility between semiconductor and life sciences employers in the Bend corridor gives nonmetro employers a sourcing advantage unavailable to leaders relying solely on traditional life sciences pipelines. Consider evaluating whether regional coordination forums, like those connecting Oregon biopharma developers, can shorten time-to-fill for hard-to-source manufacturing and technical roles before resorting to CDMO expansion.
Looking ahead
Early indicator: Watch whether Oregon's statewide push to double life sciences employment over the next decade produces visible nonmetro facility announcements, which would intensify competition for the same regulatory and manufacturing talent pool already strained statewide.
Worth watching: PacificSource's fourth round of layoffs since 2025, cutting 134 jobs across Springfield, Bend, Salem, and Portland by year-end, may release healthcare administration and compliance talent adjacent to life sciences quality and regulatory functions.
Potential inflection point: Monitor whether Oregon Employment Department's October data, due November 18, shows the 5.0%-5.3% unemployment band finally breaking, which would signal a shift in general labor availability for nonmetro support and manufacturing roles.
Emerging pressure point: Track local advertised pay for Biostatistician and Clinical Data Manager roles, both already showing significant increases, for signs that CRO and CDMO partners are bidding up the same specialist pool nonmetro employers rely on.
Sources
- Oregon Employment Department — Oregon unemployment held near 5.0%-5.3% for 19 months
- Oregon Life Sciences industry research — Oregon biotech talent concentration 2.5x national average
- Industry labor market research, Q1 2026 — Lab/R&D vacancy reached 23.2% across top 13 U.S. life sciences markets
- Oregon WARN Act filing — PacificSource layoffs of 134 workers across Oregon sites by Dec. 31
- Biopharma industry labor survey, 2026 — National quit rate at 1.9%
- Oregon state economic development research — Oregon aims to double life sciences sector employment over a decade
Methodology
Advertised pay from active employer job postings, not survey data. WageScape's median is calibrated to correct for spurious low-value postings: distribution analysis shows roughly the lowest 10% of raw values are erroneous entries, so the reported median is the 60th percentile of raw advertised pay. WageScape observes 98% of U.S. job openings daily.
Free to read and cite with attribution to WageScape. Terms of use.